Regulation of the cellular p53 tumor antigen in teratocarcinoma cells and their differentiated progeny.
about
Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogeneMolecular cloning of a cDNA specific for the murine p53 cellular tumor antigenThe ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexesLinking incomplete reprogramming to the improved pluripotency of murine embryonal carcinoma cell-derived pluripotent stem cellsTransgenic mouse model for studying the transcriptional activity of the p53 protein: age- and tissue-dependent changes in radiation-induced activation during embryogenesis.Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc.Radioimmunoassay of the cellular protein p53 in mouse and human cell lines.Monoclonal antibodies displaying a novel species specificity for the primate transformation-related protein, p53.A single gene and a pseudogene for the cellular tumour antigen p53.p53, Stem Cells, and Reprogramming: Tumor Suppression beyond Guarding the Genome.The cancer treatment revolutionStabilization of the p53 transformation-related protein in mouse fibrosarcoma cell lines: effects of protein sequence and intracellular environmentTranscription regulation by mutant p53.p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors.Lineage-specific transformation after differentiation of multipotential murine stem cells containing a human oncogeneModulation of p53 protein expression during cellular transformation with simian virus 40Energy requirement for degradation of tumor-associated protein p53Abelson murine leukemia virus-transformed cells that lack p53 protein synthesis express aberrant p53 mRNA speciesLysine methylation represses p53 activity in teratocarcinoma cancer cells.Protein p53 and inducer-mediated erythroleukemia cell commitment to terminal cell divisionp53, a transformation-related cellular-encoded protein, can be used as a biochemical marker for the detection of primary mouse tumor cells.Induction of transformed cells to terminal differentiation.Expression of wild-type and mutant p53 proteins by recombinant vaccinia viruses.Characterization of the human p53 gene promoter.Evidence for free and metabolically stable p53 protein in nuclear subfractions of simian virus 40-transformed cells.The tumor suppressor p53 is bound to RNA by a stable covalent linkage.Mutations of the p53 gene in B-cell lymphoma.Regulation of ES cell differentiation by functional and conformational modulation of p53.p53 and the ribosomal protein L5 participate in high molecular mass complex formation with protein kinase CK2 in murine teratocarcinoma cell line F9 after serum stimulation and cisplatin treatment.Association between the cellular p53 and the adenovirus 5 E1B-55kd proteins reduces the oncogenicity of Ad-transformed cells.Analysis of recombinant DNA clones specific for the murine p53 cellular tumor antigen.3-Methylcholanthrene triggers the differentiation of alveolar tumor cells from canine bronchial basal cells and an altered p53 gene promotes their clonal expansion.Specific interaction between the p53 cellular tumour antigen and major heat shock proteins.Reduction in p53 synthesis during differentiation of Friend-erythroleukemia cells. Correlation with the commitment to terminal cell division.Deacetylation of p53 after nerve growth factor treatment in PC12 cells as a post-translational modification mechanism of neurotrophin-induced tumor suppressor activation.The amount of a specific cellular protein (p53) is a correlate of differentiation in embryonal carcinoma cells.
P2860
Q24298218-5A39F891-28F3-43B8-A2FE-4692E99CF4F8Q24602351-CCAF7FD4-AAB9-4C78-BF70-F0A3E7D5C440Q24608783-1F8EF972-5BB4-4589-AAA7-B59C4BADB34BQ33570419-76C3061E-D0DD-435A-8A7D-1CF7130DD114Q33886271-BBB8FD17-EB04-4997-A0A5-799BFDF4CF4FQ33890400-554032A8-27F0-4099-9580-F717985C2A2DQ33928142-40C798BF-92EB-4C8E-A5E8-8224F11683D1Q33933776-8F367E5C-AE7C-42BC-982C-E22D24BB4B9EQ34265353-FED3705E-BC31-429B-B3EE-BF3954B1F820Q35103179-FE7BB38F-AB7F-4336-A91B-D4C2FD40A860Q35778555-002E3A17-9CDB-4DA6-9CB8-0552C487F7C1Q36758893-7AF32CA4-5820-40A8-B5A6-EC93507CD3CFQ36777349-C55EDD81-9A67-452A-B138-CADCFAF4AAAAQ36895398-EF707FF4-150D-4E9A-A104-BC90C28DFE1AQ36909909-5DD9E0F6-1ECF-488E-93AC-314EDA698FD4Q36925553-35D8F97C-0EBE-44E1-B838-1F0A2F0656EFQ36941962-2F9480E7-BBE5-4F40-AFD1-DAAAD47CB580Q36942353-A892F72A-1584-4707-A6FD-E8454C033D69Q37258479-A59B5E1C-95A4-4798-9D7C-48EA471B1441Q37514996-31A8D2C3-CBCF-4A22-9964-B40B827FD12AQ37610416-5EE47950-F589-49E0-B282-F766C0C82016Q39695038-F8322E7B-9757-4591-8DE2-63343CFE6C77Q40423014-D3B43B2E-ACD6-4EEC-B108-38982FCF1204Q40648046-0B5CC6C6-6C1F-48EA-AE26-59B67EFF3321Q40670377-A91B8847-2BB6-45DC-ABF5-D7FE75B1CE25Q40677778-E4DF58FB-9B45-409B-B8C5-1DC632A9393DQ40771480-4181B569-B9ED-4855-8FE5-B6CFE64FFECFQ41007095-FEADC976-869A-4FEB-9144-136691910EC1Q41008751-1ECDC41E-CB67-4C75-A5C3-DA48C5E67CFEQ41243025-99505935-0FBD-4067-BD34-40821E464127Q41461966-07101ABA-6D28-4F10-8212-F6303A812AC5Q42491087-036F8E3E-F195-414C-A0EF-E8E02BD287B1Q43512047-9BD90716-0D89-48F0-AF62-9A8FE252EF17Q44647409-2B61A70D-8939-4C5E-A836-373AE9A933F5Q45054555-5FC57193-53F2-47B7-A944-244775D95C5EQ53564142-DBDD4BE4-2428-4ED3-9417-685E3D40C2D5
P2860
Regulation of the cellular p53 tumor antigen in teratocarcinoma cells and their differentiated progeny.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
Regulation of the cellular p53 ...... their differentiated progeny.
@en
type
label
Regulation of the cellular p53 ...... their differentiated progeny.
@en
prefLabel
Regulation of the cellular p53 ...... their differentiated progeny.
@en
P2093
P2860
P356
P1476
Regulation of the cellular p53 ...... their differentiated progeny.
@en
P2093
P2860
P304
P356
10.1128/MCB.2.4.443
P407
P577
1982-04-01T00:00:00Z